Abstract
Background
Guipi decoction (GPD) not only improves gastrointestinal (GI) function, but also depressive mood. The bioinformatics study aimed to reveal potential crosstalk genes and related pathways between depression and GI disorders. A network pharmacology approach was used to explore the molecular mechanisms and potential targets of GPD for the simultaneous treatment of depression comorbid GI disorders.
Methods
Differentially expressed genes (DEGs) of major depressive disorder (MDD) were identified based on GSE98793 and GSE19738, and GI disorders-related genes were screened from the GeneCards database. Overlapping genes between MDD and GI disorders were obtained to identify potential crosstalk genes. Protein-protein interaction (PPI) network was constructed to screen for hub genes, signature genes were identified by LASSO regression analysis, and single sample gene set enrichment analysis (ssGSEA) was performed to analyze immune cell infiltration. In addition, based on the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database, we screened the active ingredients and targets of GPD and identified the intersection targets of GPD with MDD and GI disorder-related genes, respectively. A “component-target” network was constructed using Cytoscape, the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed.
Results
The MDD-corrected dataset contained 2619 DEGs, and a total of 109 crosstalk genes were obtained. 14 hub genes were screened, namely SOX2, CRP, ACE, LEP, SHH, CDH2, CD34, TNF, EGF, BDNF, FN1, IL10, PPARG, and KIT. These genes were identified by LASSO regression analysis for 3 signature genes, including TNF, EGF, and IL10. Gamma.delta.T.cell was significantly positively correlated with all three signature genes, while Central.memory.CD4.T.cell and Central.memory.CD8.T.cell were significantly negatively correlated with EGF and TNF. GPD contained 134 active ingredients and 248 targets, with 41 and 87 relevant targets for the treatment of depression and GI disorders, respectively. EGF, PPARG, IL10 and CRP overlap with the hub genes of the disease.
Conclusion
We found that GPD may regulate inflammatory and oxidative stress responses through EGF, PPARG, IL10 and CRP targets, and then be involved in the treatment of both depression and GI disorders.
Similar content being viewed by others
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Code Availability
Custom computer code used in the study is available from the corresponding author upon reasonable request.
References
Achour M, Ferdousi F, Sasaki K et al (2021) Luteolin modulates neural stem cells fate determination: in vitro study on human neural stem cells, and in vivo study on lps-induced depression mice model. Front Cell Dev Biol 9:753279. https://doi.org/10.3389/fcell.2021.753279
Agrawal K, Chakraborty P, Dewanjee S et al (2023) Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders. Neurosci Biobehav Rev 144:104955. https://doi.org/10.1016/j.neubiorev.2022.104955
Aguado A, García Del Álamo M (2020) [gastrointestinal comorbidity and symptoms associated with depression in patients aged over 60 years]. Semergen 46 (1):27–32. https://doi.org/10.1016/j.semerg.2019.03.003
Avramidou M, Angst F, Angst J et al (2018) Epidemiology of gastrointestinal symptoms in young and middle-aged swiss adults: Prevalences and comorbidities in a longitudinal population cohort over 28 years. BMC Gastroenterol 18 (1):21. https://doi.org/10.1186/s12876-018-0749-3
Barros R, Pereira D, Callé C et al (2016) Dynamics of sox2 and cdx2 expression in barrett’s mucosa. Dis Markers 2016:1532791. https://doi.org/10.1155/2016/1532791
Beyene GT, Kalayou S, Riaz T et al (2017) Comparative proteomic analysis of neisseria meningitidis wildtype and dpra null mutant strains links DNA processing to pilus biogenesis. BMC Microbiol 17 (1):96. https://doi.org/10.1186/s12866-017-1004-8
Black CJ, Drossman DA, Talley NJ et al (2020) Functional gastrointestinal disorders: advances in understanding and management. Lancet 396 (10263):1664–1674. https://doi.org/10.1016/s0140-6736 (20)32115-2
Camilo V, Garrido M, Valente P et al (2015) Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: Role of sox2 and cdx2. Histopathology, 66 (3):343–350. https://doi.org/10.1111/his.12544
Cao Y, He R, Wang Y et al (2021) A clinical study on the treatment of patients with non-celiac reflux disease with mood disorders by combining guixin tang with esomeprazole magnesium enteric dissolve tablets. J Zhejiang Univ Tradit Chin Med 45 (10):1072–1079. https://doi.org/10.16466/j.issn1005-5509.2021.10.004
Carniel BP, Da Rocha NS (2021) Brain-derived neurotrophic factor (bdnf) and inflammatory markers: perspectives for the management of depression. Prog Neuropsychopharmacol Biol Psychiatry 108:110151. https://doi.org/10.1016/j.pnpbp.2020.110151
Chen SJ, Cui MC (2017) Systematic understanding of the mechanism of salvianolic acid a via computational target fishing. Molecules 22 (4). https://doi.org/10.3390/molecules22040644
Chen R, Wang J, Zhan R et al (2019) Integrated systems pharmacology, urinary metabonomics, and quantitative real-time pcr analysis to uncover targets and metabolic pathways of the you-gui pill in treating kidney-yang deficiency syndrome. Int J Mol Sci 20 (15). https://doi.org/10.3390/ijms20153655
Chen L, Ye T, Qi D et al (2021) Modern clinical application and progress of research on the types of diseases to be prevented and treated with guipi decoction. Chin J Exp Tradit Med Formulae 27 (15):219–226. https://doi.org/10.13422/j.cnki.syfjx.20211406
Chen L, Ye T, Wang X et al (2023) The mechanisms underlying the pharmacological effects of guipi decoction on major depressive disorder based on network pharmacology and molecular docking. Comb Chem High Throughput Screen 26 (9):1701–1728. https://doi.org/10.2174/1386207325666220831152959
Colucci-D’amato L, Speranza L, Volpicelli F (2020) Neurotrophic factor bdnf, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci 21 (20). https://doi.org/10.3390/ijms21207777
Conant K, Daniele S, Bozzelli PL et al (2017) Matrix metalloproteinase activity stimulates n-cadherin shedding and the soluble n-cadherin ectodomain promotes classical microglial activation. J Neuroinflammation 14 (1):56. https://doi.org/10.1186/s12974-017-0827-4
Coudert E, Gehant S, De Castro E et al (2023) Annotation of biologically relevant ligands in uniprotkb using chebi. Bioinformatics 39 (1). https://doi.org/10.1093/bioinformatics/btac793
Dickerson F, Adamos M, Katsafanas E et al (2017) The association between immune markers and recent suicide attempts in patients with serious mental illness: a pilot study. Psychiatry Res 255:8–12. https://doi.org/10.1016/j.psychres.2017.05.005
Dinan TG, Cryan JF (2012) Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology 37 (9):1369–1378. https://doi.org/10.1016/j.psyneuen.2012.03.007
Eustis SJ, Mccall MW, Murphy EA et al (2022) Association between gastrointestinal symptoms and depression in a representative sample of adults in the united states: findings from national health and nutrition examination survey (2005–2016). J Acad Consult Liaison Psychiatry 63 (3):268–279. https://doi.org/10.1016/j.jaclp.2021.08.008
Evrensel A, Ceylan ME (2015) The gut-brain axis: the missing link in depression. Clin Psychopharmacol Neurosci 13 (3):239–244. https://doi.org/10.9758/cpn.2015.13.3.239
Gao W, Wang W, Peng Y et al (2019) Antidepressive effects of kaempferol mediated by reduction of oxidative stress, proinflammatory cytokines and up-regulation of akt/β-catenin cascade. Metab Brain Dis 34 (2):485–494. https://doi.org/10.1007/s11011-019-0389-5
Gelle T, Samey RA, Plansont B et al (2021) Bdnf and pro-bdnf in serum and exosomes in major depression: evolution after antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 109:110229. https://doi.org/10.1016/j.pnpbp.2020.110229
Goggins BJ, Minahan K, Sherwin S et al (2021) Pharmacological hif-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function. Am J Physiol Gastrointest Liver Physiol 320 (4):G420–g438. https://doi.org/10.1152/ajpgi.00192.2020
Gold PW (2021) The pparg system in major depression: pathophysiologic and therapeutic implications. Int J Mol Sci 22 (17). https://doi.org/10.3390/ijms22179248
He X, Du X, Chen J (2022) Study on the molecular mechanism of guipi decoction against sleep deprivation based on integrated pharmacology analysis and gene expression profiling. Acta Neurobiol Exp (Wars) 82 (4):409–423. https://doi.org/10.55782/ane-2022-039
Huang HC, Wen XZ, Xue H et al (2019a) Phosphoglucose isomerase gene expression as a prognostic biomarker of gastric cancer. Chin J Cancer Res 31 (5):771–784. https://doi.org/10.21147/j.issn.1000-9604.2019.05.07
Huang TT, Lai JB, Du YL et al (2019b) Current understanding of gut microbiota in mood disorders: an update of human studies. Front Genet 10:98. https://doi.org/10.3389/fgene.2019.00098
Huang J, Cai Y, Su Y et al (2021) Gastrointestinal symptoms during depressive episodes in 3256 patients with major depressive disorders: findings from the nssd. J Affect Disord 286:27–32. https://doi.org/10.1016/j.jad.2021.02.039
Jiang T, Hu S, Dai S et al (2022a) Programming changes of hippocampal mir-134-5p/sox2 signal mediate the susceptibility to depression in prenatal dexamethasone-exposed female offspring. Cell Biol Toxicol 38 (1):69–86. https://doi.org/10.1007/s10565-021-09590-4
Jiang X, Yi S, Liu Q et al (2022b) Asperosaponin vi ameliorates the cms-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via ppar-γ pathway. J Neuroinflammation 19 (1):115. https://doi.org/10.1186/s12974-022-02478-y
Kubota K, Inoue K, Hashimoto R et al (2009) Tumor necrosis factor receptor-associated protein 1 regulates cell adhesion and synaptic morphology via modulation of n-cadherin expression. J Neurochem 110 (2):496–508. https://doi.org/10.1111/j.1471-4159.2009.06099.x
Lach G, Schellekens H, Dinan TG et al (2018) Anxiety, depression, and the microbiome: a role for gut peptides. Neurotherapeutics 15 (1):36–59. https://doi.org/10.1007/s13311-017-0585-0
László ZI, Lele Z (2022) Flying under the radar: Cdh2 (n-cadherin), an important hub molecule in neurodevelopmental and neurodegenerative diseases. Front Neurosci 16:972059. https://doi.org/10.3389/fnins.2022.972059
Li G, Zhao M, Cheng X et al (2020) Fg-4592 improves depressive-like behaviors through hif-1-mediated neurogenesis and synapse plasticity in rats. Neurotherapeutics 17 (2):664–675. https://doi.org/10.1007/s13311-019-00807-3
Li B, Du P, Du Y et al (2021a) Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats. Life Sci 269:119008. https://doi.org/10.1016/j.lfs.2020.119008
Li D, Feng Y, Tian M et al (2021b) Gut microbiota-derived inosine from dietary barley leaf supplementation attenuates colitis through pparγ signaling activation. Microbiome 9 (1):83. https://doi.org/10.1186/s40168-021-01028-7
Li T, Li X, Zhang J et al (2022a) Chemical component analysis of the traditional chinese medicine guipi tang and its effects on major depressive disorder at molecular level. Heliyon 8 (12):e12182. https://doi.org/10.1016/j.heliyon.2022.e12182
Li Y, Lv C, Fan H et al (2022b) Clinical application and modern research progress of guipi decoction and its additions and subtractions. J Shanxi Univ Tradit Chin Med 23 (01):65–67. https://doi.org/10.19763/j.cnki.2096-7403.2022.01.14
Li Y, Wang ML, Zhang B et al (2022c) Antidepressant-like effect and mechanism of ginsenoside rd on rodent models of depression. Drug Des Devel Ther 16:843–861. https://doi.org/10.2147/dddt.S351421
Li Y, Xu E, Kang L et al (2023) New progress in the study of the treatment of depression by the guipi decoction and its combination formulae. Chin Arch Tradit Chin Med, :1–13
Liang M, Shao X, Chen C et al (2022) The basis and mechanism of rosae rugosae flos antidepressants based on network. Shandong Sci 35 (04):38–48
Lin XL, Tang XD, Cai ZX et al (2016) Nps/nprs signaling pathways may be involved in depression-induced loss of gastric icc by decreasing the production of mscf. PLoS ONE 11 (2):e0149031. https://doi.org/10.1371/journal.pone.0149031
Liu D, Huo X, Gao L et al (2018) Nf-κb and nrf2 pathways contribute to the protective effect of licochalcone a on dextran sulphate sodium-induced ulcerative colitis in mice. Biomed Pharmacother 102:922–929. https://doi.org/10.1016/j.biopha.2018.03.130
Liu X, Wei F, Liu H et al (2021) Integrating hippocampal metabolomics and network pharmacology deciphers the antidepressant mechanisms of xiaoyaosan. J Ethnopharmacol 268:113549. https://doi.org/10.1016/j.jep.2020.113549
Luo S, Lin R, Liao X et al (2021) Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer. Sci Rep 11 (1):23674. https://doi.org/10.1038/s41598-021-03086-1
Maes M, Mihaylova I, Kubera M et al (2011) Igm-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord 135 (1–3):414–418. https://doi.org/10.1016/j.jad.2011.08.023
Malhi GS, Mann JJ (2018) Depress Lancet 392 (10161):2299–2312. https://doi.org/10.1016/s0140-6736 (18)31948-2
Manu KA, Shanmugam MK, Ramachandran L et al (2015) Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of nf-κb signaling cascade in gastric cancer. Cancer Lett 363 (1):28–36. https://doi.org/10.1016/j.canlet.2015.03.033
Martin-Subero M, Anderson G, Kanchanatawan B et al (2016) Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectr 21 (2):184–198. https://doi.org/10.1017/s1092852915000449
Mayer EA, Craske M, Naliboff BD (2001) Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry 62 Suppl 8:28–36 discussion 37
Memon AA, Sundquist K, Ahmad A et al (2017) Role of il-8, crp and epidermal growth factor in depression and anxiety patients treated with mindfulness-based therapy or cognitive behavioral therapy in primary health care. Psychiatry Res 254:311–316. https://doi.org/10.1016/j.psychres.2017.05.012
Mercurio S, Serra L, Pagin M et al (2022) Deconstructing sox2 function in brain development and disease. Cells 11 (10). https://doi.org/10.3390/cells11101604
Midenfjord I, Polster A, Sjövall H et al (2019) Anxiety and depression in irritable bowel syndrome: exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterol Motil 31 (8):e13619. https://doi.org/10.1111/nmo.13619
Mikocka-Walus A, Knowles SR (2018) Editorial: anxiety and depression in inflammatory bowel disease. Aliment Pharmacol Ther 48 (6):686–687. https://doi.org/10.1111/apt.14912
Painsipp E, Wultsch T, Shahbazian A et al (2007) Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 150 (3):522–536. https://doi.org/10.1016/j.neuroscience.2007.09.024
Piao CL, Luo JL, Jin D et al (2019) Utilizing network pharmacology to explore the underlying mechanism of radix salviae in diabetic retinopathy. Chin Med 14:58. https://doi.org/10.1186/s13020-019-0280-7
Qin X, Wang W, Wu H et al (2020) Pparγ-mediated microglial activation phenotype is involved in depressive-like behaviors and neuroinflammation in stressed c57bl/6j and ob/ob mice. Psychoneuroendocrinology 117:104674. https://doi.org/10.1016/j.psyneuen.2020.104674
Qu Y, Li X, Xu F et al (2021) Kaempferol alleviates murine experimental colitis by restoring gut microbiota and inhibiting the lps-tlr4-nf-κb axis. Front Immunol 12:679897. https://doi.org/10.3389/fimmu.2021.679897
Ren J, Chen Y, Ma X et al (2018) Effect of guipi decoction on functional dyspepsia with anxiety and gastrointestinal motility. Guangming J Tradit Chin Med 33 (18):2682–2685
Roudsari NM, Lashgari NA, Zandi N et al (2020) Pparγ: a turning point for irritable bowel syndrome treatment. Life Sci 257:118103. https://doi.org/10.1016/j.lfs.2020.118103
Ru J, Li P, Wang J et al (2014) Tcmsp: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6:13. https://doi.org/10.1186/1758-2946-6-13
Şenkal E, Durankuş F, Çam S et al (2020) Increased serum bdnf and probdnf levels in children with irritable bowel syndrome. J Psychosom Res 137:110216. https://doi.org/10.1016/j.jpsychores.2020.110216
Shao Y, Wang K, Xiong X et al (2021) The landscape of interactions between hypoxia-inducible factors and reactive oxygen species in the gastrointestinal tract. Oxid Med Cell Longev, 2021:8893663. https://doi.org/10.1155/2021/8893663
Shibata T, Yamagata H, Uchida S et al (2013) The alteration of hypoxia inducible factor-1 (hif-1) and its target genes in mood disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 43:222–229. https://doi.org/10.1016/j.pnpbp.2013.01.003
Sibelli A, Chalder T, Everitt H et al (2016) A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset. Psychol Med 46 (15):3065–3080. https://doi.org/10.1017/s0033291716001987
Söderquist F, Syk M, Just D et al (2020) A cross-sectional study of gastrointestinal symptoms, depressive symptoms and trait anxiety in young adults. BMC Psychiatry 20 (1):535. https://doi.org/10.1186/s12888-020-02940-2
Song MT, Ruan J, Zhang RY et al (2018) Astragaloside iv ameliorates neuroinflammation-induced depressive-like behaviors in mice via the pparγ/nf-κb/nlrp3 inflammasome axis. Acta Pharmacol Sin 39 (10):1559–1570. https://doi.org/10.1038/aps.2017.208
Soret R, Schneider S, Bernas G et al (2020) Glial cell-derived neurotrophic factor induces enteric neurogenesis and improves colon structure and function in mouse models of hirschsprung disease. Gastroenterology 159 (5):1824–1838e1817. https://doi.org/10.1053/j.gastro.2020.07.018
Sroor HM, Hassan AM, Zenz G et al (2019) Experimental colitis reduces microglial cell activation in the mouse brain without affecting microglial cell numbers. Sci Rep 9 (1):20217. https://doi.org/10.1038/s41598-019-56859-0
Sun W, Chen Y, Wang L et al (2023) Gram-scale preparation of quercetin supramolecular nanoribbons for intestinal inflammatory diseases by oral administration. Biomaterials 295:122039. https://doi.org/10.1016/j.biomaterials.2023.122039
Takajo T, Tomita K, Tsuchihashi H et al (2019) Depression promotes the onset of irritable bowel syndrome through unique dysbiosis in rats. Gut Liver 13 (3):325–332. https://doi.org/10.5009/gnl18296
Tian Z, Liu SB, Wang YC et al (2013) Neuroprotective effects of formononetin against nmda-induced apoptosis in cortical neurons. Phytother Res 27 (12):1770–1775. https://doi.org/10.1002/ptr.4928
Tian J, Wen Z, Guo X et al (2016) Systematic evaluation of the efficacy and safety of guipi decoction in the treatment of depression. Chin J Inf Tradit Chin Med 23 (04):36–40
Tian J, Wang XQ, Tian Z (2022) Focusing on formononetin: recent perspectives for its neuroprotective potentials. Front Pharmacol 13:905898. https://doi.org/10.3389/fphar.2022.905898
Wang B, Chen D, Jiang R et al (2022a) Tip60 buffers acute stress response and depressive behaviour by controlling pparγ-mediated transcription. Brain Behav Immun 101:410–422. https://doi.org/10.1016/j.bbi.2022.01.022
Wang H, Zhang J, Li H et al (2022b) Fn1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers. Front Oncol 12:918719. https://doi.org/10.3389/fonc.2022.918719
Wegner M (2010) All purpose sox: the many roles of sox proteins in gene expression. Int J Biochem Cell Biol 42 (3):381–390. https://doi.org/10.1016/j.biocel.2009.07.006
Wen Y, Liu C, Liao J et al (2019) Incidence and risk factors of depressive symptoms in 4 years of follow-up among mid-aged and elderly community-dwelling chinese adults: findings from the china health and retirement longitudinal study. BMJ Open 9 (9):e029529. https://doi.org/10.1136/bmjopen-2019-029529
Wen S, He L, Zhong Z et al (2021) Stigmasterol restores the balance of treg/th17 cells by activating the butyrate-pparγ axis in colitis. Front Immunol 12:741934. https://doi.org/10.3389/fimmu.2021.741934
Wu J, Zhang X, Wang Y et al (2018) Licochalcone a suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the akt signaling pathway. Oncol Rep 39 (3):1181–1190. https://doi.org/10.3892/or.2017.6155
Wu Y, Murray GK, Byrne EM et al (2021) Gwas of peptic ulcer disease implicates helicobacter pylori infection, other gastrointestinal disorders and depression. Nat Commun 12 (1):1146. https://doi.org/10.1038/s41467-021-21280-7
Xiao Y, Xin L, Li L et al (2019) Quercetin and kaempferol increase the intestinal absorption of isorhamnetin coexisting in elaeagnus rhamnoides (l.) a. Nelson (elaeagnaceae) extracts via regulating multidrug resistance-associated protein 2. Phytomedicine 53:154–162. https://doi.org/10.1016/j.phymed.2018.09.028
Xu HY, Zhang YQ, Liu ZM et al (2019) Etcm: an encyclopaedia of traditional chinese medicine. Nucleic Acids Res 47 (D1):D976–d982. https://doi.org/10.1093/nar/gky987
Yan M, Chen J, Liu F et al (2021) Disrupted regional homogeneity in major depressive disorder with gastrointestinal symptoms at rest. Front Psychiatry 12:636820. https://doi.org/10.3389/fpsyt.2021.636820
Yang Y, Huang T, Zhang H et al (2023) Formononetin improves cardiac function and depressive behaviours in myocardial infarction with depression by targeting gsk-3β to regulate macrophage/microglial polarization. Phytomedicine 109:154602. https://doi.org/10.1016/j.phymed.2022.154602
Yao W, Cao Q, Luo S et al (2022) Correction: microglial erk-nrbp1-creb-bdnf signaling in sustained antidepressant actions of (r)-ketamine. Mol Psychiatry 27 (3):1630. https://doi.org/10.1038/s41380-021-01417-2
Ye Y, Jiang M, Hong X et al (2023) Quercetin alleviates deoxynivalenol-induced intestinal damage by suppressing inflammation and ferroptosis in mice. J Agric Food Chem 71 (28):10761–10772. https://doi.org/10.1021/acs.jafc.3c02027
Zhang Y, Qin G, Liu DR et al (2019) Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 25 (2):269–281. https://doi.org/10.3748/wjg.v25.i2.269
Zhang C, Liu H, Yang L et al (2020) Correlation between active ingredients of guipi decoction and modern pharmacology. Chin Tradit Pat Med 42 (06):1553–1558
Zhang L, Tang M, Xie X et al (2021a) Ginsenoside rb1 induces a pro-neurogenic microglial phenotype via pparγ activation in male mice exposed to chronic mild stress. J Neuroinflammation 18 (1):171. https://doi.org/10.1186/s12974-021-02185-0
Zhang T, Yuan K, Wang Y et al (2021b) Identification of candidate biomarkers and prognostic analysis in colorectal cancer liver metastases. Front Oncol 11:652354. https://doi.org/10.3389/fonc.2021.652354
Zhang K, Wang F, Zhai M et al (2023) Hyperactive neuronal autophagy depletes bdnf and impairs adult hippocampal neurogenesis in a corticosterone-induced mouse model of depression. Theranostics 13 (3):1059–1075. https://doi.org/10.7150/thno.81067
Zhao G, Liu L, Peek RM Jr. et al (2016) Activation of epidermal growth factor receptor in macrophages mediates feedback inhibition of m2 polarization and gastrointestinal tumor cell growth. J Biol Chem 291 (39):20462–20472. https://doi.org/10.1074/jbc.M116.750182
Zhu C, Li M, Qu M (2014) Guipi decoction treated 30 cases of depression with deficiency of heart and spleen. Chin J Exp Tradit Med Formulae 20 (16):209–213. https://doi.org/10.13422/j.cnki.syfjx.2014160209
Acknowledgements
Some pictures are drawn by the OmicStudio tools at https://www.omicstudio.cn/tool.
Funding
This work was supported by the Scientific Research Projects in Key Areas of Traditional Chinese Medicine of Tianjin Municipal Health and Health Commission (grant number 2023004).
Author information
Authors and Affiliations
Contributions
Huayi Liu and Menglin Liu designed the study. Genhao Fan Performed the operation. Menglin Liu analyzed the data. Menglin Liu and Genhao Fan co-drafted and revised the article. Menglin Liu and Genhao Fan contribution is equal in this work, and it is necessary to consider them as co-first authors.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no competing interests.
Ethics approval
Not applicable.
Consent to participate
All participants gave their consent to participate prior to participating in the study.
Consent for publication
All participants agreed to publish the study results.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, M., Fan, G. & Liu, H. Integrated bioinformatics and network pharmacology identifying the mechanisms and molecular targets of Guipi Decoction for treatment of comorbidity with depression and gastrointestinal disorders. Metab Brain Dis 39, 183–197 (2024). https://doi.org/10.1007/s11011-023-01308-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-023-01308-1